Geron (STU:GON) Interest Expense : €-9.07 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Geron Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Geron's interest expense for the three months ended in Mar. 2024 was € -3.16 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-9.07 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Geron's Operating Income for the three months ended in Mar. 2024 was € -51.64 Mil. Geron's Interest Expense for the three months ended in Mar. 2024 was € -3.16 Mil. Geron did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Geron Interest Expense Historical Data

The historical data trend for Geron's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Interest Expense Chart

Geron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.63

-3.31

-6.50

-7.62

Geron Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.80	-1.85	-1.94	-2.13	-3.16

Geron Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-9.07 Mil.

Geron (STU:GON) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Geron's Interest Expense for the three months ended in Mar. 2024 was €-3.16 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-51.64 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €12.92 Mil.

Geron's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Geron did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Geron (STU:GON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

GERN:USA

Address

919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404

Website

https://www.geron.com

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. the company operates as a single segment, the development of therapeutic products for oncology.

Geron (STU:GON) Headlines

No Headlines